11
TITLE: Lung cancer: a brief review of epidemiology and screening
AUTHORS: Claudia Gouvinhas; Ramon Andrade De Mello; Daniela Oliveira; Jose Manuel Castro Lopes ; Pedro Castelo Branco; Ricardo Sales dos Santos; Venceslau Hespanhol ; Daniel Humberto Pozza ;
PUBLISHED: 2018, SOURCE: FUTURE ONCOLOGY, VOLUME: 14, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 13
12
TITLE: Cost-effectiveness and budget impact of lung cancer immunotherapy in South America: strategies to improve access
AUTHORS: Pedro Aguiar Jr; Auro Del Giglio; Luke Alastair Perry; Jahan Penny Dimri; Hani Babiker; Hakaru Tadokoro; Gilberto Lopes; Ramon Andrade De Mello;
PUBLISHED: 2018, SOURCE: IMMUNOTHERAPY, VOLUME: 10, ISSUE: 10
INDEXED IN: WOS
13
TITLE: MetaLanc9 as a novel biomarker for non-small cell lung cancer: promising treatments via a PGK1-activated AKT/mTOR pathway
AUTHORS: Ramon Andrade De Mello; Pedro Nazareth Aguiar; Hakaru Tadokoro; Tallita Meciany Farias Vieira; Pedro Castelo Branco; Gilberto de Lima Lopes; Daniel Humberto Pozza ;
PUBLISHED: 2018, SOURCE: JOURNAL OF THORACIC DISEASE, VOLUME: 10, ISSUE: S16
INDEXED IN: WOS CrossRef: 8
14
TITLE: What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?
AUTHORS: Ramon Andrade De Mello; Luis Castelo-Branco; Pedro Castelo-Branco; Daniel Humberto Pozza ; Louis Vermeulen; Sofia Palacio; Matthew Salzberg; Craig C Lockhart;
PUBLISHED: 2018, SOURCE: American Society of Clinical Oncology Educational Book, ISSUE: 38
INDEXED IN: CrossRef: 3
15
TITLE: Potential role of immunotherapy in advanced non-small-cell lung cancer
AUTHORS: Ramon Andrade de Mello; Ana Flavia Veloso; Paulo Esrom Catarina; Sara Nadine; Georgios Antoniou;
PUBLISHED: 2017, SOURCE: ONCOTARGETS AND THERAPY, VOLUME: 10
INDEXED IN: WOS
16
TITLE: Angiogenesis and apatinib: a new hope for patients with advanced gastric cancer?
AUTHORS: Ramon Andrade de Mello; Jailson de Oliveira; Georgios Antoniou;
PUBLISHED: 2017, SOURCE: FUTURE ONCOLOGY, VOLUME: 13, ISSUE: 4
INDEXED IN: Scopus WOS
17
TITLE: The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC
AUTHORS: Aguiar, PN; Perry, LA; Penny Dimri, J; Babiker, H; Tadokoro, H; de Mello, RA; Lopes, GL;
PUBLISHED: 2017, SOURCE: ANNALS OF ONCOLOGY, VOLUME: 28, ISSUE: 9
INDEXED IN: Scopus WOS
18
TITLE: MicroRNAs in lung cancer
AUTHORS: Diana Castro; Marcia Moreira; Alexandra Monteiro Gouveia ; Daniel Humberto Pozza ; Ramon Andrade De Mello;
PUBLISHED: 2017, SOURCE: ONCOTARGET, VOLUME: 8, ISSUE: 46
INDEXED IN: Scopus WOS CrossRef: 60
19
TITLE: Comparative Outcome Assessment of EGFR TKIs for the Treatment of Advanced Non-Small-Cell Lung Cancer: A Network Meta-Analysis
AUTHORS: Ramon Andrade De Mello; Pedro Aguiar; Paloma Cabral; Fablo Chaves; Davi Liu; Joao Paulo Soares; Giannis Mountzios; Hakaru Tadokoro; Gilberto De Lima Lopes;
PUBLISHED: 2017, SOURCE: JOURNAL OF THORACIC ONCOLOGY, VOLUME: 12, ISSUE: 1
INDEXED IN: WOS
20
TITLE: Immunotherapy with checkpoint inhibitors for lung cancer: novel agents, biomarkers and paradigms
AUTHORS: Ines de Paula Monteiro; Raffaele Califano; Giannis Mountzios; Ramon Andrade de Mello;
PUBLISHED: 2016, SOURCE: FUTURE ONCOLOGY, VOLUME: 12, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef
Page 2 of 5. Total results: 50.